Pharmacogenomics as a Service - NW GMSA PROGRESS PROGRAMME
The "Pharmacogenetics as a Service" component of the PROGRESS Programme, aims to develop a digital solution which allows the persistence and messaging of pharmacogenetic data. This will be performed in the context of an initial pilot as part of the wider PROGRESS Programme, but any solution should have the potential to scale across the NHS.
Buyer
Manchester University NHS Foundation Trust
Value
£119,880
Published
11 May 2023
Closes
12 Apr 2023
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Selective
Category
Goods
Contract starts
16 Apr 2023
Contract ends
16 Dec 2024
CPV classifications
48000000
Software package and information systems
Lots
Lot default Pharmacogenomics as a Service - NW GMSA PROGRESS PROGRAMME
£119,880
The "Pharmacogenetics as a Service" component of the PROGRESS Programme, aims to develop a digital solution which allows the persistence and messaging of pharmacogenetic data. This will be performed in the context of an initial pilot as part of the wider PROGRESS Programme, but any solution should have the potential to scale across the NHS.
Documents
Unlock document linkAwarded contract notice on Contracts Finder
11 May 2023
Awarded contract notice on Contracts Finder
Award notice · Web page
Untitled document
Not provided
Contract signed · PDF
Contains public sector information licensed under the Open Government Licence v3.0.